双星药业 (871824.OC)

+ 收藏

利润表(双星药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 30,040,717.9850,017,713.7224,962,174.3450,348,714.7926,525,852.04
 营业收入(元) 30,040,717.9850,017,713.7224,962,174.3450,348,714.7926,525,852.04
二、营业总成本(元) 17,926,711.5938,925,794.4618,279,301.0733,274,764.8815,110,137.75
 营业成本(元) 7,546,932.9715,419,509.358,380,347.7017,211,247.938,550,120.36
 研发费用(元) 2,272,598.058,491,210.423,218,611.297,162,972.792,241,123.89
 营业税金及附加(元) 259,291.03345,633.84180,595.85454,113.24300,447.78
 销售费用(元) 2,600,694.966,654,990.543,039,336.644,873,624.032,994,861.35
 管理费用(元) 4,341,312.536,503,327.142,795,216.243,037,742.86798,372.96
 财务费用(元) 905,882.051,511,123.17665,193.35535,064.03225,211.41
  其中:利息费用(元) 845,106.431,463,845.06648,220.98494,386.50216,366.92
  其中:利息收入(元) 5,181.4811,313.986,823.589,091.973,128.21
三、其他经营收益
 资产减值损失(元) 92,885.85257,867.52153,799.47-845,007.17-
 信用减值损失(元) -2,114,973.45-637,702.57-1,603,979.73-593,800.00-995,167.05
 其他收益(元) 951,042.594,231,072.00---
四、营业利润(元) 11,042,961.3814,943,156.215,232,693.0115,635,142.7410,420,547.24
 加:营业外收入(元) -92.671,430,000.311,351,370.031,104,986.09
 减:营业外支出(元) -3,649.373,525.438,635.35102.02
五、利润总额(元) 11,042,961.3814,939,599.516,659,167.8916,977,877.4211,525,431.31
 减:所得税费用(元) 1,516,805.67990,592.70787,926.071,044,201.961,579,539.65
六、净利润(元) 9,526,155.7113,949,006.815,871,241.8215,933,675.469,945,891.66
(一)按经营持续性分类
  持续经营净利润(元) 9,526,155.7113,949,006.815,871,241.8215,933,675.469,945,891.66
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 9,526,155.7113,949,006.815,871,241.8215,933,675.469,945,891.66
 扣除非经常性损益后的净利润(元) 8,717,769.5110,355,071.534,658,738.1714,792,351.789,006,740.20
七、每股收益
 一、基本每股收益(元) 0.170.250.100.290.19
 二、稀释每股收益(元) 0.170.250.100.290.19
九、综合收益总额(元) 9,526,155.7113,949,006.815,871,241.8215,933,675.469,945,891.66
 归属于母公司所有者的综合收益总额(元) 9,526,155.7113,949,006.815,871,241.8215,933,675.469,945,891.66
公告日期 2024-08-282024-04-252023-08-292023-04-272022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院